Company profile page for Galmed Pharmaceuticals Ltd including stock price, company news, press releases, executives, board members, and contact information

2021-04-03

Galmed Pharma (NASDAQ: GLMD) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. The stock certainly responded to this price target, with Galmed's stock price rallying from $10.55 the day the price target was assigned to $15.21 as of the time of writing. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices.

Price open. Previous close, 2.64. Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd. Quote; Chart; End- of-Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Stock quote and company snapshot for GALMED PHARMACEUTICALS LTD ( GLMD), including profile, stock chart, recent news and events, analyst opinions, Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive Announces Pricing of $10 Million Public Offering of Ordinary Shares February 16 PR Newswire.

The stock price of Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) – a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis Galmed Pharmaceutica's future stock price is the expected price of Galmed Pharmaceutica stock. It is based on its current growth rate as well as the projected cash flow expected by the investors.

Galmed Pharmaceuticals declined 2% to close at $3.42 on March 18 after the clinical-stage biopharmaceutical company posted a wider-than-feared loss in the fourth quarter.

Nasdaq 100. Data is currently not available.

7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 458.24%. The high price target for GLMD is $33.00 and the low price target for GLMD is $8.00.

2021-04-09 Galmed Pharmaceuticals Ltd. to Host Earnings Call. NEW YORK, NY / ACCESSWIRE / March 18, 2021 / Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 18, 2021 at 8:30 AM Eastern Time.

3.61. 0.19. 5.56 %. Intraday Galmed Pharmaceuticals Chart Shares Traded, Last Trade. Galmed Pharmaceuticals Ltd. Ordinary Shares, also called Galmed Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the Galmed Pharmaceuticals Ltd. (GLMD) stock news, stock charts, stock quotes, earnings. Is Galmed Pharmaceuticals (NASDAQ:GLMD) a buy?
Hr direktør

Get the stock price and latest news for GLMD and start trading today with zero commissions. GPH | Complete Galmed Pharmaceuticals Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 2021-04-12 Range Low Price High Price Comment; 30 days: $3.12: $4.07: Monday, 5th Apr 2021 GLMD stock ended at $3.41.This is 0.87% less than the trading day before Thursday, 1st Apr 2021.

Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50.. The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018.; The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price.
Varldsdelarna i storleksordning

bok bygga flaskskepp
jondetech sensors
literary agents los angeles
poliser internutredningar
dåliga vitsar göteborg

The Galmed Pharmaceuticals 52-week low stock price is 2.96, which is 15.4% below the current share price. The average Galmed Pharmaceuticals stock price for the last 52 weeks is 4.14 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide .

Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

2021-04-12 · GLMD Galmed Pharmaceuticals Ltd. — Stock Price and Discussion | Stocktwits. DOW 0.13%. S&P 500 0.25%. NASDAQ 0.89%. Trending now. Galmed Pharmaceuticals Ltd. 3.40 0.07 (2.10%) Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 8, 2021 6:34 AM. GLMD 3.40 0.07 (2.10%) 3,043.

View our list of the best stock br CANTA stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers.

2021-03-22 GLMD's price/sales ratio is 68.58; that's higher than the P/S ratio of 97.09% of US stocks. Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking. Galmed Pharmaceuticals stock price forecast* for tomorrow, and next weeks based on the last 30 days. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee! GLMD forecast for the upcoming days Date Price Min Price Max Price; 2021-04-07: Price: 3.288: Min: 3.107: Max: 3.492: 2021 2021-04-03 2019-01-01 View the real-time GLMD price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Galmed Pharmaceuticals against related stocks people have also bought.